Mersana Therapeutics Information
Contact top employees from
Mersana Therapeutics
Summary
Mersana Therapeutics is a public company that has been in the industry for 24 years. The company currently specializes in the Biotechnology, Pharmaceuticals, Biotechnology areas. The position of the President & CEO is occupied by Anna Protopapas. Its headquarters is located at Cambridge, Massachusetts, USA. The number of employees ranges from 100 to 250. The Mersana Therapeutics annual revenue is estimated at < 1M. Total funding of the company - $197.1M. To connect with Mersana Therapeutics employee register on SignalHire.
Industries
Biotechnology
Headquarters Location
Employees Size
100-200 employees
Specialties
cancer research, antibody drug conjugates, drug development, bioconjugation, oncology
DMA Code
Greater Boston
Founded
2001
Operating Status
Independent Company
Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 2000 | Public Company | 100 - 250 | 34.8M | $211.4M | |
| 2007 | Public Company | 250 - 500 | 221.9M | $142.1M | |
| 2006 | Public Company | 25 - 100 | 27.2M | $463.9M | |
| 2008 | Public Company | 100 - 250 | 66.4M | $290.6M | |
| 2011 | Public Company | 100 - 250 | 156.7M | $808.7M | |
| 2003 | Privately Held | 100 - 250 | 12.8M | $42.5M | |
| 2011 | Privately Held | 25 - 100 | 9.8M | $7.3M | |
| 2004 | Privately Held | 1 - 25 | 2.8M | $22.6M | |
| 2007 | Privately Held | 25 - 100 | < 1M | $162.3M | |
| 2004 | Public Company | 25 - 100 | 123.3M | $98M | |
| 2013 | Public Company | 25 - 100 | 65.8M | $52.5M | |
| 1996 | Public Company | 100 - 250 | 144.1M | $45M | |
| 2008 | Public Company | 100 - 250 | 103.7M | $246.2M | |
| 2005 | - | 100-200 | - | $- | |
| 2010 | - | - | $- |
Employees Turnover 3 quarter 2025
Number of employees switched from or switched to
Total number all of employee turnover
Ex-employees switched to
Length of Employment
Employee tenure at Mersana Therapeutics shows a diverse range of experience levels:
2% have been with the company for less than 1 year14% for 1–2 years29% for 3–4 years15% for 5–7 years15% for 8–10 years25% have over 11 years of service at Mersana TherapeuticsEx-employees positions
In Company
In New Company
Contact top employees from
Mersana Therapeutics
Brigitte Eichner
Executive Director, Corporate Counsel
Tori Caldwell
Director, Talent Acquisition
David Moore
Manager, SEC Reporting
Ashish Mandelia
Vice President, Chief Accounting Officer
Olivia Pijanowski
Senior Clinical Enrollment Specialist, Clinical Development
Robert Burger
Vice President, Clinical Development
Natalie Keirstead
SVP, Nonclinical Development
Chelsey Faircloth
Principal Associate Scientist, Biology
Niyanta Kumar
Associate Director
Nitin Dixit
Director
Caroline Rogalski
Senior Clinical Trial Manager
Chelsea Bradshaw
Senior Director, Biostatistics
Scott David Collins
Director, Non-Clinical Operations. Non-Clinical Development
Cate Coombs
Director of Accounting
Casey Coons
Associate Director, Lab Operations
Richard Hurd
Vice President, Scientific Affairs
Leah Tempesta
Associate Director Procurement
Srikanth Chebrolu
Sr Director IT Operations
Katherine McKenzie
Senior Clinical Trial Associate
Naniye Malli
Director, Translational Research & Medicine
Eleonora Presman
Associate Director Quality Control
Brian DeSchuytner
Chief Operating Officer & Chief Financial Officer
June Buchanan
Executive Director Clinical Operations
Aubri Lang
Director, Clinical Operations
Sean Donohue
Senior Director/Director of Clinical Operations
Richard Fredericks
Senior Director - Regulatory, Quality & Clinical Solutions (RQCS)
Maria Makarovskaya
Outsourcing & Vendor Management
Chuck Miller
Senior Vice President, Regulatory Affairs
